Dr. Epstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Usc Keck School Of Medicine
2011 Zonal Avenue, Hmr 205
Los Angeles, CA 90089Phone+1 818-426-9595Fax+1 323-442-3049- Is this information wrong?
Education & Training
- University of Southern California/LAC+USC Medical CenterResidency, Pathology-Anatomic and Clinical, 1984 - 1985
- Stanford University School of MedicineClass of 1978
Certifications & Licensure
- CA State Medical License 1985 - 2025
Publications & Presentations
PubMed
- Immune Priming with Spatially Fractionated Radiation Therapy.Lauren Lukas, Hualin Zhang, Karen Cheng, Alan Epstein> ;Current Oncology Reports. 2023 Dec 1
- 5 citationsDeletion of monoamine oxidase A in a prostate cancer model enhances anti-tumor immunity through reduced immune suppression.Jessica A Lapierre, Lauren A Geary, Julie K Jang, Alan L Epstein, Frank Hong, Jean C Shih> ;Biochemical and Biophysical Research Communications. 2022 Dec 17
- 18 citationsEliciting anti-cancer immunity by genetically engineered multifunctional exosomes.Qinqin Cheng, Zhefu Dai, Goar Smbatyan, Alan L Epstein, Heinz-Josef Lenz, Yong Zhang> ;Molecular Therapy. 2022 Sep 7
- Join now to see all
Press Mentions
- Congress of Clinical Rheumatology Reloaded: West Follows East with Fresh Topics, SpeakersAugust 27th, 2021
Grant Support
- Monoclonal Antibodies Against T-Regulatory CellsNational Cancer Institute2004–2005
- TNT Imaging To Monitor The Efficacy Of Cancer TherapyNational Cancer Institute2000–2002
- Immunotherapy Of Lymphomas With Lym-1 And Lym-2National Cancer Institute1994
- Immunotherapy Of Human Lymphomas With Lym-1 And Lym-2National Cancer Institute1992–1993
- Tumor Necrosis Treatment Of Human CancerNational Cancer Institute1991–1993
- Immunotherapy Of Human Lymphomas W/Lym-1 &Lym-2National Cancer Institute1988–1990
- Development And Characterization Of Myeloma Cell LinesNational Cancer Institute1985–1987
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: